[63] Interactions of phenoxyl radical of antitumor drug, etoposide, with reductants in solution and in cell and nuclear homogenates: Electron spin resonance and high-performance liquid chromatography
- 1 January 1994
- book chapter
- Published by Elsevier
- Vol. 234, 631-642
- https://doi.org/10.1016/0076-6879(94)34134-6
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Generation and recycling of radicals from phenolic antioxidantsArchives of Biochemistry and Biophysics, 1990
- Tyrosinase-Induced Free Radical Formation From VP-16,213: Relationship To CytotoxicityFree Radical Research Communications, 1990
- Characterization of free radicals produced during oxidation of etoposide (VP-16) and its catechol and quinone derivatives. An ESR studyBiochemistry, 1989
- Biochemical basis for the interactions of type I and type II topoisomerases with DNAPharmacology & Therapeutics, 1989
- Mechanism of Action of Antitumor Drug Etoposide: A ReviewJNCI Journal of the National Cancer Institute, 1988
- BIOLOGICAL ACTIVITIES OF PHTHALOCYANINES—IV. TYPE II SENSITIZED PHOTOOXIDATION OF L‐TRYPTOPHAN AND CHOLESTEROL BY SULFONATED METALLO PHTHALOCYANINESPhotochemistry and Photobiology, 1986
- Vitamin E: application of the principles of physical organic chemistry to the exploration of its structure and functionAccounts of Chemical Research, 1986
- DNA topoisomerase II as a target of antineoplastic drug therapyCancer and Metastasis Reviews, 1985
- Free radical metabolism of VP-16 and inhibition of anthracycline-induced lipid peroxidationBiochemical Pharmacology, 1983